Acquiring convalescent specimens to isolate and identify potent monoclonal antibodies against COVID-19
||Male and Female Patients
||Brett Gray: 000-000-0000 / email@example.com
Due to the high volume of inquiries, please inquire through RecruitMe. A study to isolate and determine the antibody response in patients who have recovered from COVID-19 for the development of monoclonal antibodies for prevention and treatment of coronavirus infections. We are doing this study to develop antibodies against coronavirus to prevent and treat diseases like COVID-19. This study will require one study visit for blood draw in order to examine the antibodies created by your cells, using advanced techniques in the laboratory. If you have been diagnosed with COVID-19 and have recovered, you may be eligible for this study. Due to the volume of inquiries, please send an inquiry through RecruitMe by clicking the "Do You Qualify" button.
This study is closed
David Ho, MD
|Are you between the ages of 18-65?
|Have you tested positive for COVID-19?